Suritozole
Suritozole is a nootropic and neuroprotective agent that has been studied for its potential effects on cognitive function and memory. It belongs to the class of benzothiazoles and has been investigated primarily for its potential use in treating Alzheimer's disease and other neurodegenerative disorders.
Mechanism of Action[edit | edit source]
Suritozole is believed to function as a positive allosteric modulator of the GABA_A receptor, which plays a crucial role in the regulation of neurotransmission in the central nervous system. By modulating this receptor, suritozole may enhance synaptic plasticity and improve cognitive processes.
Potential Therapeutic Uses[edit | edit source]
Alzheimer's Disease[edit | edit source]
Suritozole has been studied for its potential to alleviate symptoms of Alzheimer's disease, a progressive neurodegenerative disorder characterized by memory loss, cognitive decline, and behavioral changes. Research suggests that suritozole may help improve memory and learning in patients with Alzheimer's disease by enhancing synaptic function and protecting neurons from degeneration.
Cognitive Enhancement[edit | edit source]
In addition to its potential therapeutic use in Alzheimer's disease, suritozole has been investigated for its nootropic properties, which may benefit individuals seeking to enhance their cognitive abilities. Studies have shown that suritozole may improve memory, attention, and learning in healthy individuals.
Side Effects and Safety[edit | edit source]
The safety profile of suritozole is still under investigation. Common side effects reported in clinical trials include headache, nausea, and dizziness. Long-term safety and efficacy studies are needed to fully understand the potential risks and benefits of suritozole.
Research and Development[edit | edit source]
Suritozole is currently in the experimental stages of research, with ongoing studies aimed at understanding its full range of effects and potential therapeutic applications. Further research is needed to determine its efficacy and safety in larger, more diverse populations.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
-
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
